Memphasys tech shows advantages in small-scale sperm preparation trial

ASX-listed reproductive biotechnology company Memphasys has announced results showing “clear benefits” of its Felix technology versus two widely used technologies in a Japanese trial, with results from a larger-scale trial expected to be shared in late-2024. According to an ASX statement from the company on Monday, the Felix System (pictured) outperformed a sperm preparation method…

First Graphene, Bisley & Company reach distro deal

Nanomaterials developer and producer First Graphene has announced a five-year distribution agreement with privately-owned industrial products distributor Bisley & Company. According to an ASX announcement from First Graphene on Thursday, the non-exclusive distribution deal will see the company’s PureGRAPH sold throughout Australia and New Zealand through Bisley, and represented “a significant milestone” in its commercialisation…

State government awards support to IDT for nation’s first ADC factory

Pharmaceutical manufacturer IDT Australia has announced that it has been awarded a Victorian government grant to assist in the establishment of an Australian-first facility for oncology drugs. In an ASX statement on Monday, IDT said it has established relationships with Antibody-Drug-Conjugate (ADC) biotech companies, including a master services  agreement with Japanese pharmaceutical company Nagase &…